SK3302004A3 - Tuhé liekové formy s riadeným uvoľňovaním účinnej látky - nový systém dodávania liečiva so zníženým rizikom nekontrolovaného uvoľňovania účinnej látky - Google Patents

Tuhé liekové formy s riadeným uvoľňovaním účinnej látky - nový systém dodávania liečiva so zníženým rizikom nekontrolovaného uvoľňovania účinnej látky Download PDF

Info

Publication number
SK3302004A3
SK3302004A3 SK330-2004A SK3302004A SK3302004A3 SK 3302004 A3 SK3302004 A3 SK 3302004A3 SK 3302004 A SK3302004 A SK 3302004A SK 3302004 A3 SK3302004 A3 SK 3302004A3
Authority
SK
Slovakia
Prior art keywords
pharmaceutical composition
water
composition according
weight
insoluble
Prior art date
Application number
SK330-2004A
Other languages
English (en)
Slovak (sk)
Inventor
M. Zahirul I. Khan
Aleksandra Krajacic
Zdravka Knezevic
Snjezana Vodopija-Mandic
Original Assignee
Pliva Istra�Ivanje I Razvoj D.O.O.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Istra�Ivanje I Razvoj D.O.O. filed Critical Pliva Istra�Ivanje I Razvoj D.O.O.
Publication of SK3302004A3 publication Critical patent/SK3302004A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK330-2004A 2002-02-11 2002-03-27 Tuhé liekové formy s riadeným uvoľňovaním účinnej látky - nový systém dodávania liečiva so zníženým rizikom nekontrolovaného uvoľňovania účinnej látky SK3302004A3 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HR20020124A HRP20020124A2 (en) 2002-02-11 2002-02-11 Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping
PCT/HR2002/000018 WO2003074033A1 (en) 2002-02-11 2002-03-27 Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping

Publications (1)

Publication Number Publication Date
SK3302004A3 true SK3302004A3 (sk) 2005-04-01

Family

ID=27772919

Family Applications (1)

Application Number Title Priority Date Filing Date
SK330-2004A SK3302004A3 (sk) 2002-02-11 2002-03-27 Tuhé liekové formy s riadeným uvoľňovaním účinnej látky - nový systém dodávania liečiva so zníženým rizikom nekontrolovaného uvoľňovania účinnej látky

Country Status (17)

Country Link
US (1) US20050118266A1 (sr)
EP (1) EP1474112A1 (sr)
JP (1) JP2006507216A (sr)
AU (1) AU2004205184A1 (sr)
BG (1) BG108870A (sr)
CA (1) CA2476050A1 (sr)
CZ (1) CZ2004931A3 (sr)
EE (1) EE200400110A (sr)
HR (1) HRP20020124A2 (sr)
HU (1) HUP0500097A3 (sr)
IS (1) IS7386A (sr)
NO (1) NO20043818L (sr)
PL (1) PL371787A1 (sr)
RS (1) RS70704A (sr)
RU (1) RU2004127237A (sr)
SK (1) SK3302004A3 (sr)
WO (1) WO2003074033A1 (sr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2244324B1 (es) * 2004-03-25 2006-11-16 Ferrer Internacional, S.A. Composiciones diureticas de liberacion prolongada.
US20060280789A1 (en) * 2004-12-27 2006-12-14 Eisai Research Institute Sustained release formulations
US20060246003A1 (en) * 2004-12-27 2006-11-02 Eisai Co. Ltd. Composition containing anti-dementia drug
US20090208579A1 (en) * 2004-12-27 2009-08-20 Eisai R & D Management Co., Ltd. Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
US8481565B2 (en) * 2004-12-27 2013-07-09 Eisai R&D Management Co., Ltd. Method for stabilizing anti-dementia drug
DE102006051020A1 (de) * 2006-10-26 2008-04-30 Evonik Röhm Gmbh Verwendung von (Meth)acrylat-Copolymeren in Retard-Arzneiformen zur Verringerung des Einflusses von Ethanol auf die Wirkstofffreisetzung
WO2009042718A1 (en) * 2007-09-25 2009-04-02 Neosync, Inc. Systems and methods for controlling and billing neuro-eeg synchronization therapy
US8926490B2 (en) * 2008-09-24 2015-01-06 Neosync, Inc. Systems and methods for depression treatment using neuro-EEG synchronization therapy
WO2011017466A1 (en) 2009-08-06 2011-02-10 Neosync, Inc. Systems and methods for modulating the electrical activity of a brain using neuro-eeg synchronization therapy
US20120183611A1 (en) * 2009-09-25 2012-07-19 Norvartis Ag Oral pharmaceutical composition comprising diclofenac
EP2498857B1 (en) 2009-11-12 2020-04-29 Neosync, INC. Systems and methods for neuro-eeg synchronization
EP2540294B1 (en) 2010-02-22 2016-08-03 Daiichi Sankyo Company, Limited Sustained-release solid preparation for oral use
WO2011102504A1 (ja) 2010-02-22 2011-08-25 第一三共株式会社 経口用徐放性固形製剤
EP2544667B1 (en) * 2010-03-09 2018-11-14 Alkermes Pharma Ireland Limited Alcohol resistant enteric pharmaceutical compositions
CN104768552A (zh) 2012-09-03 2015-07-08 第一三共株式会社 含有盐酸氢吗啡酮的口服持续释放药物组合物
WO2014060857A1 (en) * 2012-10-19 2014-04-24 Wockhardt Limited Pharmaceutical compositions of diclofenac or salts thereof
US10588576B2 (en) 2014-08-15 2020-03-17 Neosync, Inc. Methods and device for determining a valid intrinsic frequency
JP1602547S (sr) 2017-01-17 2018-04-23

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN156886B (sr) * 1981-08-22 1985-11-30 Council Scient Ind Res
NL8500724A (nl) * 1985-03-13 1986-10-01 Univ Groningen Inrichtingen voor geregelde afgifte van werkzame stoffen, alsmede werkwijze ter vervaardiging daarvan.
DE3822095A1 (de) * 1988-06-30 1990-01-04 Klinge Co Chem Pharm Fab Neue arzneimittelformulierung sowie verfahren zu deren herstellung
AU645003B2 (en) * 1988-11-08 1994-01-06 Takeda Chemical Industries Ltd. Sustained release preparations
US4948581A (en) * 1989-02-17 1990-08-14 Dojin Iyaku-Kako Co., Ltd. Long acting diclofenac sodium preparation
JP2572673B2 (ja) * 1990-07-25 1997-01-16 エスエス製薬株式会社 徐放性錠剤
WO1994008576A1 (en) * 1992-10-16 1994-04-28 Glaxo Group Limited Taste-masking compositions of ranitidine
US6183778B1 (en) * 1993-09-21 2001-02-06 Jagotec Ag Pharmaceutical tablet capable of liberating one or more drugs at different release rates
US5965161A (en) * 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
DE19524753A1 (de) * 1995-07-07 1997-01-23 Lohmann Therapie Syst Lts Schichttablette zur kontrollierten Freisetzung von Wirkstoffen
ATE220543T1 (de) * 1996-04-23 2002-08-15 Janssen Pharmaceutica Nv Rasch-freisetzende ph-unabhängige feste dosisformen enthaltend cisaprid
KR19990044257A (ko) * 1996-05-20 1999-06-25 디르크 반테 생체이용율이 개선된 항진균성 조성물
US6294199B1 (en) * 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin

Also Published As

Publication number Publication date
CZ2004931A3 (cs) 2005-03-16
BG108870A (en) 2005-12-30
PL371787A1 (en) 2005-06-27
HUP0500097A2 (hu) 2005-07-28
HUP0500097A3 (en) 2008-04-28
IS7386A (is) 2004-08-05
RU2004127237A (ru) 2005-04-20
NO20043818L (no) 2004-09-30
CA2476050A1 (en) 2003-09-12
RS70704A (sr) 2006-10-27
WO2003074033A8 (en) 2004-07-08
JP2006507216A (ja) 2006-03-02
US20050118266A1 (en) 2005-06-02
EE200400110A (et) 2004-10-15
AU2004205184A1 (en) 2005-03-03
WO2003074033A1 (en) 2003-09-12
EP1474112A1 (en) 2004-11-10
HRP20020124A2 (en) 2003-10-31

Similar Documents

Publication Publication Date Title
KR101406767B1 (ko) 프라미펙솔 또는 약제학적으로 허용되는 이의 염을함유하는 연장 방출성 정제 제형, 이의 제조방법 및 이의용도
US7374781B2 (en) Sustained release formulations containing acetaminophen and tramadol
CA2483199C (en) High drug load tablet of imatinib
SK3302004A3 (sk) Tuhé liekové formy s riadeným uvoľňovaním účinnej látky - nový systém dodávania liečiva so zníženým rizikom nekontrolovaného uvoľňovania účinnej látky
US20090124702A1 (en) Pharmaceutical Compositions of Metformin
IL161491A (en) Tamsulosin tablets
US20110195120A2 (en) Sustained Release Pharmaceutical Composition Containing Metformin Hydrochloride
JP2014196334A (ja) クエチアピンを含む徐放性医薬組成物
JPH03500288A (ja) 徐放性ニフェジピン製剤
KR20010031952A (ko) 카르베디롤을 위한 신규 경구 투여형
HRP940198A2 (en) Retarded-action microtablet made of beta-phenylpropiophenone derivatives
CA2781826A1 (en) Controlled release pharmaceutical compositions of galantamine
US20150359795A1 (en) High drug load pharmaceutical compositions with controllable release rate and production methods thereof
EP2480234B1 (en) Sustained release composition of ranolazine
EP2010158B1 (en) Controlled release formulations comprising uncoated discrete unit(s) and an extended release matrix
KR20090086128A (ko) 메만틴 약학 조성물
WO2006123213A1 (en) Modified release formulations of gliclazide
WO2022153330A1 (en) Pharmaceutical compositions comprising acalabrutinib
CA3048968A1 (en) Oral pharmaceutical composition of lurasidone and preparation thereof
PL204079B1 (pl) Stały doustny preparat chlorowodorku tamsulozyny o przedłużonym uwalnianiu i sposób jego wytwarzania
SK286119B6 (sk) Lieková forma obsahujúca zaleplon
KR20200077911A (ko) 잘토프로펜 함유 서방성 의약 조성물
WO2015150948A1 (en) Modified release solid oral pharmaceutical compositions of cyclobenzaprine or a salt thereof
WO2013111147A1 (en) Extended release compositions of nevirapine
WO2016042566A1 (en) Extended release formulation of trimetazidine

Legal Events

Date Code Title Description
FC9A Refused patent application